S-1 with leucovorin for gastric cancer: how far can it go?

Lancet Oncol. 2016 Jan;17(1):12-4. doi: 10.1016/S1470-2045(15)00478-7. Epub 2015 Nov 28.
No abstract available

Publication types

  • Comment

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Female
  • Humans
  • Male
  • Neoplasm Recurrence, Local / drug therapy*
  • Stomach Neoplasms / drug therapy*